Genetic mutations are changes in the DNA sequence that can lead to cancer. Identifying these mutations helps in understanding the etiology of cancer and developing targeted therapies. For instance, mutations in the BRCA1 and BRCA2 genes significantly increase the risk of breast and ovarian cancers, leading to the development of PARP inhibitors as a targeted therapy.
